GlassScriptPhysician profile
Adam C Ellison
NPI 1730394669
$7,651.15
in general payments reported to CMS, 2019-2025
10 companies · $546 in 2025
The $546 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,462 · 2020: $1,214 · 2021: $12.64 · 2022: $2,754 · 2023: $1,307 · 2024: $356 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210 · Travel and Lodging: $710 · Education: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.25 |
| Travel and Lodging | $709.73 |
| Education | $288.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,864.80 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Flex Revive |
| Microport Orthopedics INC | $3,299.19 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $128.56 | 2019 | |
| Shoulder Innovations, INC. | $122.19 | 2025 | Inset System |
| Orthalign INC | $92.23 | 2022 | |
| Acumed LLC | $85.69 | 2024-2025 | Acumed, Acumed, Innate Implant |
| Smith+Nephew, INC. | $19.00 | 2019 | |
| Avanos Medical | $14.61 | 2019 | |
| Depuy Synthes Sales INC. | $14.20 | 2024 | Monovisc |
| Si-Bone, INC. | $10.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Ellison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.